Aldeyra Therapeut (ALDX) Misses Q3 EPS by 4c

Aldeyra Therapeut (NASDAQ: ALDX) reported Q3 EPS of ($0.36), $0.04 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Aldeyra Therapeut (ALDX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
• Apple Touched $5 Trillion and Then Gave It Back. Gabriel Adams, Senior Markets Strategist at Swiftvale, on Reading a Milestone and a Reversal in the Same Week